Novel biomarker for AD
With the rapidly progressing development of therapies for Alzheimer’s Disease (AD) treatment, comes the need for sensitive diagnostics. Within the Oxford-McGill-ZNZ Partnership, the groups of Dr. med. Luka Kulic, of the University of Zurich and […]